MARILYNN MARCHIONE

In this file photo, vials of the drug Remdesivir on display during a news conference about the start of a study with use of the drug in severely ill patients at the University Hospital Eppendorf in Hamburg, Germany, on April 8, 2020, amid the coronavirus pandemic. (Ulrich Perrey/Pool/AFP/Getty Images/TNS) 1799060 1799060

October 22, 2020 at 1:52 pm

FDA approves first COVID-19 drug: antiviral remdesivir

U.S. regulators on Thursday approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given to hospitalized patients through an IV. The drug, which...

Business

A bottle containing the drug Remdesivir is held by a health worker at the Institute of Infectology of Kenezy Gyula Teaching Hospital of the University of Debrecen in Debrecen, Hungary, Thursday Oct. 15, 2020. A large study led by the World Health Organization released on Friday, Oct. 16, 2020, suggests that the antiviral drug did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the medicine a standard of care in the United States and many other countries. The results do not negate the previous ones, and the WHO study was not as rigorous as the earlier one led by the U.S. National Institutes of Health. But they add to concerns about how much value the pricey drug gives because none of the studies have found it can improve survival. (Zsolt Czegledi/MTI via AP) MTI101 MTI101

October 16, 2020 at 5:45 am

WHO study finds remdesivir didn’t help COVID-19 patients

A large study led by the WHO suggests that the costly antiviral drug remdesivir did not help hospitalized COVID-19 patients, in contrast to an earlier...

October 13, 2020 at 1:36 pm

Possible safety issue spurs pause of COVID-19 antibody study

Independent monitors have paused enrollment in a study testing the COVID-19 antiviral drug remdesivir plus an experimental antibody therapy being developed by Eli Lilly that’s...

Business

In this undated image from video provided by Regeneron Pharmaceuticals on Friday, Oct. 2, 2020, vials are inspected at the company’s facilities in New York state, for efforts on an experimental coronavirus antibody drug. Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help the immune system eliminate it. (Regeneron via AP)

October 8, 2020 at 10:07 am

Antibody drugs are no cure but seem promising for COVID-19

They’re not cures and it’s not likely that everyone will be able to get them. But experimental antibody drugs like the one the president was...

October 7, 2020 at 5:46 am

Lilly seeks emergency use of its antibody drug for COVID-19

A drug company says it has asked the U.S. government to allow emergency use of an experimental antibody therapy based on early results from a...

Business

October 6, 2020 at 11:15 pm

Ethicists say Trump special treatment raises fairness issues

Regeneron revealed how rare it was for anyone to get the drug it gave President Trump outside of studies testing its safety and effectiveness. The...

Nation & World

October 6, 2020 at 11:00 pm

2 scientists win Nobel chemistry prize for gene-editing tool VIEW

STOCKHOLM (AP) — The Nobel Prize in chemistry went to two researchers Wednesday for a gene-editing tool that has revolutionized science by providing a way...

October 4, 2020 at 11:00 pm

3 win Nobel medicine prize for discovering hepatitis C virus VIEW

STOCKHOLM (AP) — Three scientists won the Nobel Prize in medicine Monday for discovering the liver-ravaging hepatitis C virus, a breakthrough that led to cures...

In this undated image from video provided by Regeneron Pharmaceuticals on Friday, Oct. 2, 2020, scientists work with a bioreactor at a company facility in New York state, for efforts on an experimental coronavirus antibody drug. Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help the immune system eliminate it. (Regeneron via AP) NY864 NY864 ( / The Associated Press)

October 2, 2020 at 4:18 pm

Trump gets experimental drug aimed at curbing severe illness

The president was given the experimental drug at the White House on Friday before he was taken to Walter Reed hospital.

President Donald Trump speaks during the first presidential debate with Democratic presidential candidate former Vice President Joe Biden Tuesday, Sept. 29, 2020, at Case Western University and Cleveland Clinic, in Cleveland. (AP Photo/Patrick Semansky) DBT378 DBT378

October 2, 2020 at 7:21 am

Trump’s age, health woes raise his risk for COVID-19 illness

President Donald Trump has several strikes against him — age, obesity, elevated cholesterol and being male — that could put him at greater risk of...

1
2
3
…
53
Last